Management of intrahepatic cholestasis of pregnancy

References

• Joshi D, James A, Quaglia A, et al. Liver disease in pregnancy. Lancet 2010;375(9714):594-605
   PubMed Web of Science ®Google Scholar
• Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33(6):1012-21
   PubMed Web of Science ®Google Scholar
• Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15(17):2049-66
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004;40(2):467-74
   PubMed Web of Science ®Google Scholar
• Kenyon AP, Piercy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002;109(3):282-8
   PubMed Web of Science ®Google Scholar
• Williamson C, Hems LM, Goulis DG, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 2004;111(7):676-81
   PubMed Web of Science ®Google Scholar
• Abu-Hayyeh S, Papacleovoulou G, Williamson C. Nuclear receptors, bile acids and cholesterol homeostasis series - bile acids and pregnancy. Mol Cell Endocrinol 2013;368(1-2):120-8
   PubMed Web of Science ®Google Scholar
• Arrese M, Macias RI, Briz O, et al. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 2008;10:e9
   PubMedGoogle Scholar
• Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol 2014;124(1):120-33
   PubMed Web of Science ®Google Scholar
• Reyes H, Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000;32(2):94-106
   PubMed Web of Science ®Google Scholar
• Geenes V, Lovgren-Sandblom A, Benthin L, et al. The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid. PLoS ONE 2014;9(1):e83828
   PubMed Web of Science ®Google Scholar
• Glantz A, Reilly SJ, Benthin L, et al. Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology 2008;47(2):544-51
   PubMed Web of Science ®Google Scholar
• Abu-Hayyeh S, Martinez-Becerra P, Sheikh Abdul Kadir SH, et al. Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites. J Biol Chem 2010;285(22):16504-12
   PubMed Web of Science ®Google Scholar
• Abu-Hayyeh S, Papacleovoulou G, Lovgren-Sandblom A, et al. Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype. Hepatology 2013;57(2):716-26
   PubMed Web of Science ®Google Scholar
• Kremer AE, Bolier R, Dixon PH, et al. Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy. J Hepatol 2015;62(4):897-904
   PubMed Web of Science ®Google Scholar
• Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010;139(3):1008-18, 18 e1.
   PubMed Web of Science ®Google Scholar
• Dixon PH, van Mil SW, Chambers J, et al. Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 2009;58(4):537-44
   PubMed Web of Science ®Google Scholar
• Eloranta ML, Heinonen S, Mononen T, Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clin Genet 2001;60(1):42-5
   PubMed Web of Science ®Google Scholar
• Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353(9148):210-11
   PubMed Web of Science ®Google Scholar
• Keitel V, Vogt C, Haussinger D, Kubitz R. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology 2006;131(2):624-9
   PubMed Web of Science ®Google Scholar
• Van Mil SW, Milona A, Dixon PH, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007;133(2):507-16
   PubMed Web of Science ®Google Scholar
• Zimmer V, Mullenbach R, Simon E, et al. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int 2009;29(8):1286-8
   PubMed Web of Science ®Google Scholar
• Wasmuth HE, Glantz A, Keppeler H, et al. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 2007;56(2):265-70
   PubMed Web of Science ®Google Scholar
• Dixon PH, Wadsworth CA, Chambers J, et al. A comprehensive analysis of common genetic variation around six candidate Loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol 2014;109(1):76-84
   PubMed Web of Science ®Google Scholar
• Heinonen S, Eloranta ML, Heiskanen J, et al. Maternal susceptibility locus for obstetric cholestasis maps to chromosome region 2p13 in Finnish patients. Scand J Gastroenterol 2001;36(7):766-70
   PubMed Web of Science ®Google Scholar
• Bull LN, Hu D, Shah S, et al. Intrahepatic Cholestasis of Pregnancy (ICP) in U.S. Latinas and Chileans: Clinical features, Ancestry Analysis, and Admixture Mapping. PLoS ONE 2015;10(6):e0131211
   Web of Science ®Google Scholar
• Reyes H, Baez ME, Gonzalez MC, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000;32(4):542-9
   PubMed Web of Science ®Google Scholar
• Wikstrom Shemer E, Marschall HU. Decreased 1,25-dihydroxy vitamin D levels in women with intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2010;89(11):1420-3
   PubMed Web of Science ®Google Scholar
• Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG 2013;120(6):717-23
   PubMed Web of Science ®Google Scholar
• Germain AM, Kato S, Carvajal JA, et al. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003;189(2):577-82
   PubMed Web of Science ®Google Scholar
• Sepulveda WH, Gonzalez C, Cruz MA, Rudolph MI. Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol 1991;42(3):211-15
   PubMed Web of Science ®Google Scholar
• Perez MJ, Macias RI, Duran C, et al. Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid. J Hepatol 2005;43(2):324-32
   PubMed Web of Science ®Google Scholar
• Williamson C, Gorelik J, Eaton BM, et al. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci (Lond) 2001;100(4):363-9
   PubMed Web of Science ®Google Scholar
• Sheikh Abdul Kadir SH, Miragoli M, Abu-Hayyeh S, et al. Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes. PLoS One 2010;5(3):e9689
   PubMed Web of Science ®Google Scholar
• Geenes VL, Lim YH, Bowman N, et al. A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 2011;32(12):1026-32
   PubMed Web of Science ®Google Scholar
• Wikstrom Shemer E, Thorsell M, Ostlund E, et al. Stereological assessment of placental morphology in intrahepatic cholestasis of pregnancy. Placenta 2012;33(11):914-18
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977;50(3):313-18
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 1984;22(2):91-4
   PubMed Web of Science ®Google Scholar
• Lee RH, Kwok KM, Ingles S, et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 2008;25(6):341-5
   PubMed Web of Science ®Google Scholar
• Kondrackiene J, Beuers U, Zalinkevicius R, et al. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007;13(46):6226-30
   PubMed Web of Science ®Google Scholar
• Rook M, Vargas J, Caughey A, et al. Fetal outcomes in pregnancies complicated by intrahepatic cholestasis of pregnancy in a northern california cohort. PLoS ONE 2012;7(3):e28343
   PubMed Web of Science ®Google Scholar
• Brouwers L, Koster MP, Page-Christiaens GC, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol 2015;212(1):100 e1-7
   PubMed Web of Science ®Google Scholar
• Chappell LC, Gurung V, Seed PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial. BMJ 2012;344:e3799
   PubMed Web of Science ®Google Scholar
• Gurung V, Williamson C, Chappell L, et al. Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis. BMC Pregnancy Childbirth 2009;9:19
   PubMedGoogle Scholar
• Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol 2008;14(38):5781-8
   PubMed Web of Science ®Google Scholar
• Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology 2014;59(4):1482-91
   PubMed Web of Science ®Google Scholar
• Ropponen A, Sund R, Riikonen S, et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006;43(4):723-8
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wikstrom Shemer E, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology 2013;58(4):1385-91
   PubMed Web of Science ®Google Scholar
• Wikstrom Shemer EA, Stephansson O, Thuresson M, et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study. J Hepatol 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Martineau M, Raker C, Powrie R, Williamson C. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol 2014;176:80-5
   PubMed Web of Science ®Google Scholar
• Henderson CE, Shah RR, Gottimukkala S, et al. Primum non nocere: how active management became modus operandi for intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol 2014;211(3):189-96
   PubMed Web of Science ®Google Scholar
• Puljic A, Kim E, Page J, et al. The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. Am J Obstet Gynecol 2015;212(5):667 e1-5
   PubMed Web of Science ®Google Scholar
• Webster J, Chappell L, Cheng F, et al. Operative delivery rates following induction of labour for obstetric cholestasis. Obstet Med 2011;4(2):66-9
   Google Scholar
• Wikstrom Shemer EA, Thorsell M, Marschall HU, Kaijser M. Risks of emergency cesarean section and fetal asphyxia after induction of labor in intrahepatic cholestasis of pregnancy: a hospital-based retrospective cohort study. Sex Reprod Healthc 2013;4(1):17-22
   PubMedGoogle Scholar
• EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51(2):237-67
   PubMed Web of Science ®Google Scholar
• Lammert F, Marschall HU, Matern S. Intrahepatic Cholestasis of Pregnancy. Curr Treat Options Gastroenterol 2003;6(2):123-32
   PubMedGoogle Scholar
• Gurung V, Middleton P, Milan SJ, et al. Interventions for treating cholestasis in pregnancy. Cochrane Database Syst Rev 2013;6:CD000493
   PubMed Web of Science ®Google Scholar
• Palma J, Reyes H, Ribalta J, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992;15(6):1043-7
   PubMed Web of Science ®Google Scholar
• Diaferia A, Nicastri PL, Tartagni M, et al. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996;52(2):133-40
   PubMed Web of Science ®Google Scholar
• Nicastri PL, Diaferia A, Tartagni M, et al. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1998;105(11):1205-7
   PubMedGoogle Scholar
• Floreani A, Paternoster D, Melis A, Grella PV. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol 1996;67(2):109-13
   PubMed Web of Science ®Google Scholar
• Roncaglia N, Locatelli A, Arreghini A, et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG 2004;111(1):17-21
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005;42(6):1399-405
   PubMed Web of Science ®Google Scholar
• Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005;129(3):894-901
   PubMed Web of Science ®Google Scholar
• Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006;34(5):383-91
   PubMed Web of Science ®Google Scholar
• Liu Y, Qiao F, Liu H, Liu D. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. J Huazhong Univ Sci Technolog Med Sci 2006;26(3):350-2
   PubMedGoogle Scholar
• Bacq Y, Sentilhes L, Reyes HB, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology 2012;143(6):1492-501
   PubMed Web of Science ®Google Scholar
• Joutsiniemi T, Timonen S, Leino R, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial. Arch Gynecol Obstet 2014;289(3):541-7
   PubMed Web of Science ®Google Scholar
• Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006;3(6):318-28
   PubMedGoogle Scholar
• Geenes VL, Dixon PH, Chambers J, et al. Characterisation of the nuclear receptors FXR, PXR and CAR in normal and cholestatic placenta. Placenta 2011;32(7):535-7
   PubMed Web of Science ®Google Scholar
• Jenkins JK, Boothby LA. Treatment of itching associated with intrahepatic cholestasis of pregnancy. Ann Pharmacother 2002;36(9):1462-5
   PubMed Web of Science ®Google Scholar
• Geenes V, Chambers J, Khurana R, et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2015;189:59-63
   PubMed Web of Science ®Google Scholar
• Marschall HU, Wagner M, Zollner G, et al. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterol 2005;129(2):476-85
   PubMed Web of Science ®Google Scholar